LY2603618 (IC-83) is a very selective checkpoint kinase 1 (Chk1) inhibitor with the potential for antitumor effects. Chk1 is an ATP-dependent serine-threonine kinase that is very important to the checkpoint monitoring system of DNA replication.
Soluble in water (<1 mg/ml) at 25 °C, DMSO (13 mg/ml) at 25 °C, and ethanol (<1 mg/ml) at 25 °C.
Store at -20° C
242.28° C (Predicted)
503.11° C at 760 mmHg (Predicted)
1.46 g/cm3 (Predicted)
n20D 1.63 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Adobe Acrobat Reader is required to reliably view, print and comment on PDF documents
bvseo_sdk, java_sdk, bvseo-3.2.0
CLOUD, getContent, 116ms
bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of
Wang et alWang et al. (PubMed ID 24928205) found that the Chk1 protein kinase inhibitor, LY2603618, caused cell cycle arrest at the G2/M phase by preventing Chk1 autophosphorylation and also increased DNA damage-mediated Chk1 phosphorylation in human lung cancer cells. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn